145 related articles for article (PubMed ID: 31544717)
21. Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT
Yuan RX; Jiang KY; Wu JW; Zhang ZX; Li MS; Li JQ; Ni F
Bioorg Med Chem Lett; 2022 Nov; 76():129006. PubMed ID: 36202190
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists.
Partyka A; Zagórska A; Kotańska M; Walczak M; Jastrzębska-Więsek M; Knutelska J; Bednarski M; Głuch-Lutwin M; Mordyl B; Janiszewska P; Wesołowska A
PLoS One; 2020; 15(8):e0237196. PubMed ID: 32764777
[TBL] [Abstract][Full Text] [Related]
23. Structural pharmacology and therapeutic potential of 5-methoxytryptamines.
Warren AL; Lankri D; Cunningham MJ; Serrano IC; Parise LF; Kruegel AC; Duggan P; Zilberg G; Capper MJ; Havel V; Russo SJ; Sames D; Wacker D
Nature; 2024 Jun; 630(8015):237-246. PubMed ID: 38720072
[TBL] [Abstract][Full Text] [Related]
24. Biased agonism in drug discovery: Is there a future for biased 5-HT
Sałaciak K; Pytka K
Pharmacol Ther; 2021 Nov; 227():107872. PubMed ID: 33905796
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
[TBL] [Abstract][Full Text] [Related]
26. Is there a role for 5-HT1A agonists in the treatment of depression?
Blier P; Ward NM
Biol Psychiatry; 2003 Feb; 53(3):193-203. PubMed ID: 12559651
[TBL] [Abstract][Full Text] [Related]
27. Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT
Newman-Tancredi A; Martel JC; Cosi C; Heusler P; Lestienne F; Varney MA; Cussac D
J Pharm Pharmacol; 2017 Sep; 69(9):1178-1190. PubMed ID: 28612503
[TBL] [Abstract][Full Text] [Related]
28. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
[TBL] [Abstract][Full Text] [Related]
29. Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands.
Chilmonczyk Z; Bojarski AJ; Pilc A; Sylte I
Int J Mol Sci; 2015 Aug; 16(8):18474-506. PubMed ID: 26262615
[TBL] [Abstract][Full Text] [Related]
30. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
Prinssen EP; Colpaert FC; Koek W
Eur J Pharmacol; 2002 Oct; 453(2-3):217-21. PubMed ID: 12398907
[TBL] [Abstract][Full Text] [Related]
31. The 5-HT1A receptor and its ligands: structure and function.
Olivier B; Soudijn W; van Wijngaarden I
Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
[TBL] [Abstract][Full Text] [Related]
32. Antidepressant-like behavioral effects of serotonin receptor agonists.
Lucki I; Singh A; Kreiss DS
Neurosci Biobehav Rev; 1994; 18(1):85-95. PubMed ID: 8170624
[TBL] [Abstract][Full Text] [Related]
33. A new class of 5-HT
Jankowska A; Satała G; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Głuch-Lutwin M; Bojarski AJ; Wyska E; Chłoń-Rzepa G
Future Med Chem; 2021 Sep; 13(18):1497-1514. PubMed ID: 34253032
[No Abstract] [Full Text] [Related]
34. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
35. Prediction of the affinity of the newly synthesised azapirone derivatives for 5-HT1A receptors based on artificial neural network analysis of chromatographic retention data and calculation chemistry parameters.
Nasal A; Bucinski A; Baczek T; Wojdelko A
Comb Chem High Throughput Screen; 2004 Jun; 7(4):313-25. PubMed ID: 15200379
[TBL] [Abstract][Full Text] [Related]
36. The 5-HT
Aguiar RP; Newman-Tancredi A; Prickaerts J; Oliveira RMW
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110210. PubMed ID: 33333136
[TBL] [Abstract][Full Text] [Related]
37. NLX-112, a highly selective 5-HT
Newman-Tancredi A; Bardin L; Auclair A; Colpaert F; Depoortère R; Varney MA
Brain Res; 2018 Jun; 1688():1-7. PubMed ID: 29555239
[TBL] [Abstract][Full Text] [Related]
38. Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study.
Becker G; Bolbos R; Costes N; Redouté J; Newman-Tancredi A; Zimmer L
Sci Rep; 2016 May; 6():26633. PubMed ID: 27211078
[TBL] [Abstract][Full Text] [Related]
39. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
